Cargando…
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]ins...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832019/ https://www.ncbi.nlm.nih.gov/pubmed/20209060 http://dx.doi.org/10.1371/journal.pone.0009540 |